DR. SUKESHI PATEL ARORA MD NPI 1386805604

NPI Information

  • NPI: 1386805604
  • Provider Name: DR. SUKESHI PATEL ARORA, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7979 WURZBACH RD
    SAN ANTONIO, TX
    ZIP 78229
  • Phone: (210) 450-1143

Map and Directions

Get Directions

NPI Details

DR. Sukeshi Patel Arora, MD is a medical oncology internal medicine in San Antonio, TX with 18 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Sukeshi Patel Arora, MD NPI is 1386805604. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

7979 WURZBACH RD
SAN ANTONIO, TX
ZIP 78229-427
Phone: (210) 450-1143

The NPI 1386805604 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Instillation of anti-cancer drug into bladder (HCPCS:51720)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)

The enumeration date for this NPI number is 6/19/2008 and was last updated on 2/28/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineN9112TEXASNo
2207RH0000XInternal MedicineHematologyN9112TEXASNo
3207RH0003XInternal MedicineHematology & OncologyN9112TEXASNo
4207RX0202XInternal MedicineMedical OncologyN9112TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1335538002OTHERTEXASCSHCN
2335538001MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.